| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 7.85e-06 | 60 | 158 | 6 | GO:0005544 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.60e-05 | 123 | 158 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.06e-04 | 136 | 158 | 7 | GO:0000149 | |
| GeneOntologyMolecularFunction | protein domain specific binding | CACNA1C CFTR PTPN22 KIF20B SRSF12 ACSL3 SH3PXD2B CLCN3 F11R SYNJ2 FMN1 PLEKHA2 ADGRL2 SRRM2 NIPBL UNC13A SHISA6 DNMT1 | 2.00e-04 | 875 | 158 | 18 | GO:0019904 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.64e-04 | 77 | 158 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 3.66e-04 | 43 | 158 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | syntaxin binding | 6.38e-04 | 87 | 158 | 5 | GO:0019905 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 1.53e-06 | 12 | 157 | 4 | GO:0099011 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 3.05e-06 | 82 | 157 | 7 | GO:0017156 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite extension | 3.47e-06 | 31 | 157 | 5 | GO:1903861 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 4.13e-06 | 15 | 157 | 4 | GO:1990504 | |
| GeneOntologyBiologicalProcess | regulation of dendrite extension | 6.47e-06 | 35 | 157 | 5 | GO:1903859 | |
| GeneOntologyBiologicalProcess | dendrite extension | 2.55e-05 | 46 | 157 | 5 | GO:0097484 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 3.61e-05 | 25 | 157 | 4 | GO:0048791 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 4.99e-05 | 10 | 157 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 5.74e-05 | 28 | 157 | 4 | GO:0032253 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 5.76e-05 | 2 | 157 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | cellular response to X-ray | 6.83e-05 | 11 | 157 | 3 | GO:0071481 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 7.28e-05 | 180 | 157 | 8 | GO:0060078 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 1.01e-04 | 299 | 157 | 10 | GO:0060560 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 1.25e-04 | 34 | 157 | 4 | GO:0032252 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.73e-04 | 153 | 157 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | developmental growth | CACNA1C KDM5B SFRP2 CPNE9 SYT3 RBBP6 SYT2 MAP7 OMG MEX3C SH3PXD2B PLAA FMN1 ASPM ANKRD11 MACF1 NIPBL UNC13A | 2.04e-04 | 911 | 157 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.18e-04 | 112 | 157 | 6 | GO:1902476 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | UNC13B WASHC2C INPP5K TRPM2 ZDHHC5 PTPN22 FAM98A MORC2 XRCC5 SH3PXD2B PTPN13 CEP120 F11R ARHGEF10 FMN1 MACF1 RP1 HAS2 ADGRL2 EIF2AK2 UNC13A | 2.75e-04 | 1189 | 157 | 21 | GO:0044087 |
| GeneOntologyCellularComponent | synaptic membrane | UNC13B CACNA1C CHRNA9 SYT3 SYT6 GRIN2A RGS7 SLC1A7 ADORA1 CLCN3 P2RX6 SCN8A ADGRL2 UNC13A SHISA6 GABRA5 | 9.26e-06 | 583 | 158 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | leading edge membrane | 3.24e-05 | 210 | 158 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1C CHRNA9 GRIN2A RGS7 SLC1A7 ADORA1 CLCN3 P2RX6 SCN8A ADGRL2 SHISA6 GABRA5 | 6.16e-05 | 405 | 158 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | axon terminus | 2.02e-04 | 210 | 158 | 8 | GO:0043679 | |
| GeneOntologyCellularComponent | presynaptic membrane | UNC13B CACNA1C GRIN2A RGS7 SLC1A7 ADORA1 SCN8A UNC13A GABRA5 | 2.66e-04 | 277 | 158 | 9 | GO:0042734 |
| GeneOntologyCellularComponent | neuron projection terminus | 4.06e-04 | 233 | 158 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | cell leading edge | MYO9B INPP5K GRIN2A ADORA1 PTPN13 CLCN3 SYNJ2 MACF1 SCIMP FGD6 SHISA6 GABRA5 | 4.31e-04 | 500 | 158 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | cell projection membrane | INPP5K SLC26A4 GRIN2A ADORA1 CLCN3 SYNJ2 PIK3CB MACF1 SCIMP SHISA6 GABRA5 | 4.50e-04 | 431 | 158 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | terminal bouton | 8.14e-04 | 96 | 158 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 8.59e-04 | 201 | 158 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | ruffle | 9.92e-04 | 206 | 158 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.32e-03 | 107 | 158 | 5 | GO:0060076 | |
| Domain | - | UNC13B CPNE9 RASA2 SYT3 SYT6 SYT2 SYT10 ESYT3 CEP120 PIK3CB UNC13A | 4.63e-08 | 148 | 156 | 11 | 2.60.40.150 |
| Domain | C2_dom | UNC13B CPNE9 RASA2 SYT3 SYT6 SYT2 SYT10 ESYT3 CEP120 PIK3CB UNC13A | 1.33e-07 | 164 | 156 | 11 | IPR000008 |
| Domain | C2 | 1.50e-07 | 131 | 156 | 10 | PF00168 | |
| Domain | C2 | 2.29e-07 | 137 | 156 | 10 | SM00239 | |
| Domain | C2 | 3.04e-06 | 142 | 156 | 9 | PS50004 | |
| Domain | Synaptotagmin | 2.04e-05 | 20 | 156 | 4 | IPR001565 | |
| Domain | Unc-13 | 2.07e-04 | 3 | 156 | 2 | IPR027080 | |
| Domain | MAP7 | 4.11e-04 | 4 | 156 | 2 | PF05672 | |
| Domain | MAP7_fam | 4.11e-04 | 4 | 156 | 2 | IPR008604 | |
| Domain | Munc13_dom-2 | 6.82e-04 | 5 | 156 | 2 | IPR014772 | |
| Domain | MHD2 | 6.82e-04 | 5 | 156 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 6.82e-04 | 5 | 156 | 2 | IPR019558 | |
| Domain | PWI | 6.82e-04 | 5 | 156 | 2 | PF01480 | |
| Domain | Membr_traf_MHD | 6.82e-04 | 5 | 156 | 2 | PF10540 | |
| Domain | - | 6.82e-04 | 5 | 156 | 2 | 1.20.1390.10 | |
| Domain | PWI_dom | 6.82e-04 | 5 | 156 | 2 | IPR002483 | |
| Domain | DUF1041 | 6.82e-04 | 5 | 156 | 2 | SM01145 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 2.31e-05 | 50 | 97 | 5 | MM14641 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 3.07e-05 | 53 | 97 | 5 | M662 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.10e-04 | 69 | 97 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.18e-04 | 70 | 97 | 5 | M41806 | |
| Pathway | REACTOME_PI_METABOLISM | 1.86e-04 | 77 | 97 | 5 | MM14590 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 MAGI1 KDM5B SETX TCF20 IFT74 CEP162 FAM98A MAP7 MEX3C FSIP2 STOX2 SH3PXD2B PTPN13 ARHGEF10 SYNJ2 TET1 ANKRD11 MACF1 PLEKHA2 CKAP2 SRRM2 FGD6 PCDH7 BICC1 DNMT1 | 3.53e-14 | 861 | 161 | 26 | 36931259 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H1-10 REXO4 SETX TCF20 RBBP6 BCLAF1 RBM26 FAM98A BCOR XRCC5 KIF20B SRSF12 CCNT1 RBM27 ZNF644 MARF1 ANKRD11 SLX4IP SRRM2 NIPBL DNMT1 | 3.78e-09 | 954 | 161 | 21 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NUSAP1 REXO4 SETX TCF20 L3MBTL2 MORC2 BCOR XRCC5 KIF20B ZNF8 FSIP2 CCNT1 ZNF644 UHRF1 ANAPC7 NIPBL DNMT1 | 4.00e-09 | 608 | 161 | 17 | 36089195 |
| Pubmed | H1-10 L3MBTL2 BCLAF1 ZDHHC5 FAM98A MAP7 TRAPPC8 XRCC5 STT3A ACSL3 PTPN13 ARHGEF10 ZNF644 ASPM ANKRD11 MRPS9 MAP7D2 MACF1 CKAP2 ADGRL2 EIF2A SRRM2 PCDH7 HERC5 DNMT1 | 2.43e-08 | 1487 | 161 | 25 | 33957083 | |
| Pubmed | NUSAP1 KATNAL2 REXO4 SETX RBBP6 RBM26 FAM98A MAP7 MORC2 BCOR ARHGEF11 RBM23 KIF20B CCNT1 ZNF800 PTPN13 SPATS2L RBM27 ANKRD11 MACF1 CKAP2 EIF2A ANAPC7 EIF2AK2 NIPBL | 2.77e-08 | 1497 | 161 | 25 | 31527615 | |
| Pubmed | L3MBTL2 MYO9B SH3PXD2B MEX3A ARHGEF10 NFKB1 ANKRD11 MAP7D2 MACF1 PLEKHA2 ADGRL2 DNMT1 | 5.49e-08 | 332 | 161 | 12 | 37433992 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | H1-10 MYO9B BCLAF1 FAM98A XRCC5 STT3A ACSL3 SH3PXD2B MRPS9 SRRM2 ANAPC7 EIF2AK2 HERC5 DNMT1 | 6.98e-08 | 486 | 161 | 14 | 30940648 |
| Pubmed | NRIP1 KDM5B ZNF536 TCF20 L3MBTL2 IFT74 BCOR KIF20B ZNF8 PTPN13 ZNF644 TET1 PLEKHA2 | 8.68e-08 | 418 | 161 | 13 | 34709266 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 9.83e-08 | 168 | 161 | 9 | 30631154 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NUSAP1 ATF7 ABCC1 H1-10 SETX TCF20 L3MBTL2 RBBP6 BCLAF1 MAP7 BCOR XRCC5 ACSL3 RBM27 ZNF644 ANKRD11 UHRF1 CKAP2 SRRM2 ANAPC7 NIPBL DNMT1 | 1.52e-07 | 1294 | 161 | 22 | 30804502 |
| Pubmed | 2.68e-07 | 57 | 161 | 6 | 29089450 | ||
| Pubmed | ZNF536 NBEAL1 RBBP6 SYT6 CD109 PTPN22 RGS7 RNFT1 HAS2 TRAV40 ADGRL2 AIM2 PCDH7 NIPBL UNC13A BICC1 SHISA6 | 2.68e-07 | 814 | 161 | 17 | 23251661 | |
| Pubmed | 3.06e-07 | 13 | 161 | 4 | 11543631 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 H1-10 REXO4 SETX TCF20 RASA2 L3MBTL2 MYO9B FAM98A XRCC5 KIF20B ACSL3 CCNT1 PLAA ZC2HC1A ASPM MACF1 EIF2A SRRM2 EIF2AK2 NIPBL DNMT1 | 3.24e-07 | 1353 | 161 | 22 | 29467282 |
| Pubmed | Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting. | 3.88e-07 | 4 | 161 | 3 | 30545844 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NUSAP1 H1-10 REXO4 RBBP6 MYO9B FAM98A XRCC5 KIF20B RBM27 ASPM UHRF1 MACF1 CKAP2 EIF2AK2 HERC5 DNMT1 | 5.42e-07 | 759 | 161 | 16 | 35915203 |
| Pubmed | SYT14L, especially its C2 domain, is involved in regulating melanocyte differentiation. | 5.80e-07 | 15 | 161 | 4 | 23999003 | |
| Pubmed | SETX WASHC2C RBBP6 BCLAF1 RBM26 MAP7 MORC2 ZNF8 ZC2HC1A RBM27 UHRF1 SRRM2 NIPBL | 7.09e-07 | 503 | 161 | 13 | 16964243 | |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 39116209 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | H1-10 REXO4 RBBP6 BCLAF1 RBM26 FAM98A XRCC5 MEX3C SRSF12 MEX3A SPATS2L RBM27 MRPS9 MACF1 SRRM2 EIF2AK2 | 1.21e-06 | 807 | 161 | 16 | 22681889 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 MAGI1 CACNA1C ATF7 NRIP1 RASA2 HYKK TRPM2 TTC14 IQCN SYT2 XRCC5 ARMC2 STT3A PTPN13 SYNJ2 ANKRD11 SLX4IP MACF1 PLEKHA2 ANKRD12 CKAP2 | 1.59e-06 | 1489 | 161 | 22 | 28611215 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.81e-06 | 123 | 161 | 7 | 26912792 | |
| Pubmed | Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells. | 1.93e-06 | 6 | 161 | 3 | 12860971 | |
| Pubmed | Control of plasma membrane lipid homeostasis by the extended synaptotagmins. | 1.93e-06 | 6 | 161 | 3 | 27065097 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 8626542 | ||
| Pubmed | NUSAP1 H1-10 ZNF536 REXO4 TCF20 L3MBTL2 RBBP6 MAP7 MORC2 BCOR XRCC5 STT3A RBM27 ZNF644 NFKB1 MARF1 MRPS9 SLX4IP SRRM2 PCDH7 NIPBL | 3.05e-06 | 1429 | 161 | 21 | 35140242 | |
| Pubmed | NUSAP1 MAP9 SETX WASHC2C RASA2 CEP162 TTC14 FAM171B BCOR SH3PXD2B PTPN13 PLAA FMN1 TET1 MACF1 ANKRD12 CKAP2 BICC1 | 3.11e-06 | 1084 | 161 | 18 | 11544199 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NRIP1 SETX WASHC2C RBBP6 MYO9B IFT74 VPS50 MAP7 BCOR KIF20B ZNF644 ASPM MACF1 | 3.94e-06 | 588 | 161 | 13 | 38580884 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M NUSAP1 H1-10 REXO4 RBBP6 BCLAF1 INPP5K CD109 MAP7 XRCC5 KIF20B STT3A SPATS2L RBM27 MRPS9 CKAP2 EIF2A EIF2AK2 DNMT1 | 6.29e-06 | 1257 | 161 | 19 | 36526897 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.48e-06 | 283 | 161 | 9 | 30585729 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | REXO4 BCLAF1 FAM98A MORC2 SH3PXD2B PTPN13 MEX3A SPATS2L RBM27 SYNJ2 MARF1 MACF1 EIF2A ANAPC7 | 7.66e-06 | 724 | 161 | 14 | 36232890 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | WASHC2C L3MBTL2 RBBP6 BCLAF1 RBM26 BCOR XRCC5 CCNT1 PTPN13 RBM27 MACF1 CKAP2 EIF2A NIPBL HERC5 DNMT1 | 7.72e-06 | 934 | 161 | 16 | 33916271 |
| Pubmed | Distinct developmental expression of synaptotagmin I and IX in the mouse brain. | 8.01e-06 | 9 | 161 | 3 | 16407767 | |
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 10531343 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | A2M NUSAP1 H1-10 MYO9B FAM98A MEX3C ACSL3 SPATS2L ZC2HC1A MARF1 MRPS9 CKAP2 EIF2AK2 SHISA6 | 8.67e-06 | 732 | 161 | 14 | 34732716 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | USP53 WASHC2C L3MBTL2 IFT74 CEP162 ARHGEF11 SH3PXD2B CEP120 ZC2HC1A SYNJ2 NFKB1 MAP7D2 CKAP2 EIF2A GGA1 | 1.11e-05 | 853 | 161 | 15 | 28718761 |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.16e-05 | 108 | 161 | 6 | 19531213 | |
| Pubmed | NUSAP1 H1-10 RBM26 FAM98A XRCC5 STT3A PLAA ASPM MRPS9 UHRF1 CKAP2 EIF2A SRRM2 ANAPC7 EIF2AK2 DNMT1 | 1.25e-05 | 971 | 161 | 16 | 33306668 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 H1-10 ZDHHC5 FAM171B SH3PXD2B F11R SYNJ2 FMN1 MACF1 PLEKHA2 ADGRL2 EIF2A | 1.40e-05 | 565 | 161 | 12 | 25468996 |
| Pubmed | NUSAP1 ATF7 SETX TCF20 BCLAF1 RBM26 PTPN22 MORC2 BCOR CCNT1 RBM27 ZNF644 EIF2A SRRM2 ANAPC7 NIPBL DNMT1 | 1.56e-05 | 1103 | 161 | 17 | 34189442 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NUSAP1 KATNAL2 REXO4 TCF20 BCLAF1 RBM26 TTC14 XRCC5 KIF20B SPATS2L RBM27 MRPS9 UHRF1 SRRM2 EIF2AK2 DNMT1 | 1.56e-05 | 989 | 161 | 16 | 36424410 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | H1-10 WASHC2C TCF20 RBBP6 BCLAF1 IQCN MORC2 BCOR ACSL3 ZNF644 SRRM2 PCDH7 NIPBL DNMT1 | 1.61e-05 | 774 | 161 | 14 | 15302935 |
| Pubmed | 1.75e-05 | 116 | 161 | 6 | 30804394 | ||
| Pubmed | UNC13B A2M NUSAP1 REXO4 SETX BCLAF1 TRPM2 RBM26 FAM98A MORC2 XRCC5 RBM23 MEX3C SPATS2L RBM27 MARF1 UHRF1 EIF2AK2 DNMT1 | 2.11e-05 | 1371 | 161 | 19 | 36244648 | |
| Pubmed | NUSAP1 ATF7 TCF20 RBBP6 BCLAF1 RBM26 MORC2 XRCC5 CCNT1 RBM27 UHRF1 EIF2A ANAPC7 EIF2AK2 NIPBL DNMT1 | 2.11e-05 | 1014 | 161 | 16 | 32416067 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 36893815 | ||
| Pubmed | Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. | 2.13e-05 | 2 | 161 | 2 | 16179258 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12871971 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17561838 | ||
| Pubmed | A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1. | 2.13e-05 | 2 | 161 | 2 | 31322780 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 2.13e-05 | 2 | 161 | 2 | 28489077 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 27154627 | ||
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 2.13e-05 | 2 | 161 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 2.13e-05 | 2 | 161 | 2 | 22066784 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23399035 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30358020 | ||
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 2.13e-05 | 2 | 161 | 2 | 32187536 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10753658 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22814762 | ||
| Pubmed | Baculovirus protein PK2 subverts eIF2α kinase function by mimicry of its kinase domain C-lobe. | 2.13e-05 | 2 | 161 | 2 | 26216977 | |
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 2.13e-05 | 2 | 161 | 2 | 28426965 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23770256 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19587046 | ||
| Pubmed | A family of RS domain proteins with novel subcellular localization and trafficking. | 2.13e-05 | 2 | 161 | 2 | 15741184 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24253042 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21914796 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 2.13e-05 | 2 | 161 | 2 | 31851910 | |
| Pubmed | Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1. | 2.13e-05 | 2 | 161 | 2 | 21311766 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 2.13e-05 | 2 | 161 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 2.13e-05 | 2 | 161 | 2 | 23229896 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23938174 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21708986 | ||
| Pubmed | UHRF1 plays a role in maintaining DNA methylation in mammalian cells. | 2.13e-05 | 2 | 161 | 2 | 17673620 | |
| Pubmed | A possible 5'-NRIP1/UHRF1-3' fusion gene detected by array CGH analysis in a Ph+ ALL patient. | 2.13e-05 | 2 | 161 | 2 | 22285022 | |
| Pubmed | Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer. | 2.13e-05 | 2 | 161 | 2 | 30217218 | |
| Pubmed | NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKR. | 2.13e-05 | 2 | 161 | 2 | 26725122 | |
| Pubmed | Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells. | 2.13e-05 | 2 | 161 | 2 | 37247564 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12070347 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 27049577 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22941344 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23070049 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 36827822 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 25189999 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20002670 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 2.13e-05 | 2 | 161 | 2 | 28772123 | |
| Pubmed | An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy. | 2.13e-05 | 2 | 161 | 2 | 31086176 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 2.13e-05 | 2 | 161 | 2 | 17267576 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21338484 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34166371 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 35613050 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 2.13e-05 | 2 | 161 | 2 | 30816091 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 2.13e-05 | 2 | 161 | 2 | 19558619 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18701688 | ||
| Pubmed | Alkalosis-induced hypoventilation in cystic fibrosis: The importance of efficient renal adaptation. | 2.13e-05 | 2 | 161 | 2 | 35173044 | |
| Pubmed | A1 adenosine receptors in microglia control glioblastoma-host interaction. | 2.13e-05 | 2 | 161 | 2 | 16951167 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11792326 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23840832 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30784582 | ||
| Pubmed | Quantitative trait loci modulate renal cystic disease severity in the mouse bpk model. | 2.13e-05 | 2 | 161 | 2 | 10864581 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 36692670 | ||
| Interaction | MAPRE3 interactions | MAP9 MYO9B IFT74 CEP162 MAP7 MEOX2 SH3PXD2B ZC2HC1A SYNJ2 MARF1 MAP7D2 MACF1 CKAP2 | 3.68e-08 | 230 | 159 | 13 | int:MAPRE3 |
| Interaction | NUP43 interactions | H1-10 REXO4 SETX TCF20 L3MBTL2 RBBP6 IFT74 BCLAF1 RBM26 TTC14 MORC2 BCOR FSIP2 ZNF644 MARF1 ANKRD11 EIF2A SRRM2 NIPBL | 5.23e-07 | 625 | 159 | 19 | int:NUP43 |
| Interaction | YWHAH interactions | USP53 MAGI1 NRIP1 KDM5B SETX TCF20 IFT74 CEP162 CFTR FAM98A MAP7 MEX3C SRSF12 STOX2 SH3PXD2B PTPN13 SYNJ2 TET1 ANKRD11 MACF1 PLEKHA2 SRRM2 FGD6 BICC1 DNMT1 | 1.77e-06 | 1102 | 159 | 25 | int:YWHAH |
| Interaction | CIT interactions | MAGI1 H1-10 NRIP1 SETX TCF20 RBBP6 MYO9B BCLAF1 CD109 HEATR5A FAM98A MAP7 XRCC5 TCEANC SYT10 RBM23 SRSF12 ACSL3 ESYT3 RBM27 PIK3CB CCDC62 UHRF1 MACF1 SRRM2 ANAPC7 EIF2AK2 NIPBL | 8.81e-06 | 1450 | 159 | 28 | int:CIT |
| Interaction | H3C3 interactions | NUSAP1 REXO4 SETX TCF20 L3MBTL2 MORC2 XRCC5 KIF20B ZNF8 FSIP2 ZNF644 UHRF1 ANAPC7 NIPBL DNMT1 | 9.21e-06 | 495 | 159 | 15 | int:H3C3 |
| Interaction | SYT10 interactions | 9.47e-06 | 6 | 159 | 3 | int:SYT10 | |
| Interaction | H2BC21 interactions | H1-10 KDM5B TCF20 SPANXN2 IFT74 BCLAF1 BCOR XRCC5 CLCN3 ZNF644 TET1 HEATR9 UHRF1 CKAP2 EIF2A SRRM2 ANAPC7 NIPBL | 1.01e-05 | 696 | 159 | 18 | int:H2BC21 |
| Interaction | ZNF330 interactions | NUSAP1 H1-10 ZNF536 REXO4 TCF20 MORC2 STT3A MEOX2 ZNF8 ZNF644 ANKRD11 UHRF1 NIPBL DNMT1 | 1.25e-05 | 446 | 159 | 14 | int:ZNF330 |
| Interaction | TRIM36 interactions | 1.91e-05 | 144 | 159 | 8 | int:TRIM36 | |
| Interaction | CGN interactions | 2.82e-05 | 152 | 159 | 8 | int:CGN | |
| Interaction | TERF2IP interactions | ZNF536 SETX TCF20 RBBP6 BCOR XRCC5 KIF20B CCNT1 RBM27 ZNF644 ANKRD11 SLX4IP SRRM2 NIPBL DNMT1 | 3.28e-05 | 552 | 159 | 15 | int:TERF2IP |
| Interaction | CDH1 interactions | MAGI1 H1-10 SFRP2 CFTR ZDHHC5 FAM171B XRCC5 SH3PXD2B ZC2HC1A F11R SYNJ2 FMN1 UHRF1 MACF1 PLEKHA2 ADGRL2 EIF2A ANAPC7 | 3.72e-05 | 768 | 159 | 18 | int:CDH1 |
| Interaction | SMC5 interactions | H1-10 REXO4 SETX TCF20 RBBP6 BCLAF1 RBM26 FAM98A BCOR XRCC5 KIF20B SRSF12 CCNT1 RBM27 ZNF644 MARF1 ANKRD11 SLX4IP SRRM2 NIPBL DNMT1 | 4.07e-05 | 1000 | 159 | 21 | int:SMC5 |
| Interaction | DCTN1 interactions | MAP9 IFT74 CEP162 CFTR VPS50 MAP7 SH3PXD2B MEX3A ZC2HC1A SYNJ2 MAP7D2 MACF1 CKAP2 EIF2A | 4.12e-05 | 497 | 159 | 14 | int:DCTN1 |
| Interaction | SOX2 interactions | A2M NUSAP1 H1-10 KDM5B ZNF536 REXO4 TCF20 MYO9B BCLAF1 FAM98A BCOR XRCC5 MEX3C ACSL3 CCNT1 SPATS2L ZC2HC1A ZNF644 MARF1 MRPS9 MACF1 CKAP2 ANAPC7 EIF2AK2 NIPBL SHISA6 | 4.89e-05 | 1422 | 159 | 26 | int:SOX2 |
| Interaction | MEX3A interactions | L3MBTL2 MYO9B SH3PXD2B MEX3A ARHGEF10 NFKB1 ANKRD11 MAP7D2 MACF1 PLEKHA2 ADGRL2 DNMT1 | 5.56e-05 | 384 | 159 | 12 | int:MEX3A |
| Interaction | MLLT3 interactions | 5.74e-05 | 85 | 159 | 6 | int:MLLT3 | |
| Interaction | CAMSAP2 interactions | 6.00e-05 | 169 | 159 | 8 | int:CAMSAP2 | |
| Interaction | HINFP interactions | 6.07e-05 | 53 | 159 | 5 | int:HINFP | |
| Interaction | LCA5 interactions | 6.10e-05 | 125 | 159 | 7 | int:LCA5 | |
| Interaction | HDAC4 interactions | STARD13 MAGI1 CACNA1C KDM5B WASHC2C SYT3 SYT6 FAM98A MORC2 BCOR SRSF12 SPATS2L FMN1 NFKB1 SCN8A ANKRD11 DNMT1 | 8.45e-05 | 744 | 159 | 17 | int:HDAC4 |
| Interaction | CTDSPL interactions | 8.94e-05 | 92 | 159 | 6 | int:CTDSPL | |
| Interaction | TRIM52 interactions | 9.03e-05 | 133 | 159 | 7 | int:TRIM52 | |
| Interaction | LCN15 interactions | 1.01e-04 | 12 | 159 | 3 | int:LCN15 | |
| Interaction | BRD7 interactions | H1-10 MYO9B BCLAF1 FAM98A XRCC5 STT3A ACSL3 SH3PXD2B PTPN13 MRPS9 SRRM2 ANAPC7 EIF2AK2 HERC5 DNMT1 | 1.62e-04 | 637 | 159 | 15 | int:BRD7 |
| Interaction | CTBP2 interactions | NRIP1 CFTR SYT6 RBM26 MAP7 OMG SYNJ2 NFKB1 MARF1 SHISA6 DNMT1 | 1.77e-04 | 370 | 159 | 11 | int:CTBP2 |
| GeneFamily | Synaptotagmins | 3.01e-06 | 17 | 111 | 4 | 765 | |
| GeneFamily | UNC13 homologs | 2.22e-04 | 4 | 111 | 2 | 836 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.31e-03 | 9 | 111 | 2 | 1234 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS | ATF7 FAT4 REXO4 SETX RBBP6 FAM171B TRAPPC8 MORC2 SLC1A7 ZNF800 PLAA ARHGEF10 SYNJ2 | 2.92e-07 | 356 | 159 | 13 | M43609 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NUSAP1 NRIP1 SETX IFT74 BCLAF1 RBM26 TRAPPC8 KIF20B STOX2 PTPN13 RBM27 ZNF644 ASPM HAS2 NIPBL MYBL1 | 2.63e-06 | 656 | 159 | 16 | M18979 |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 2.88e-06 | 144 | 159 | 8 | M5942 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 ABCC1 NRIP1 KDM5B SETX MYO9B ROR1 TRAPPC8 RGS7 KIF20B ACSL3 PTPN13 ARHGEF10 SYNJ2 NFKB1 MACF1 NIPBL MYBL1 | 4.84e-06 | 856 | 159 | 18 | M4500 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | SFRP2 BCLAF1 CFTR RBM26 TTC14 FAM98A FAM171B MEOX2 ASPM ADGRL2 HERC5 | 3.83e-05 | 404 | 159 | 11 | M19488 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NUSAP1 H1-10 L3MBTL2 KIAA0586 KIF20B SPATS2L SERTAD4 ASPM UHRF1 CKAP2 ADGRL2 DNMT1 MYBL1 | 5.46e-05 | 578 | 159 | 13 | M2368 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | NRIP1 RBBP6 PTPN22 HEATR5A CD200R1 ARHGEF10 SCN8A ANKRD11 MACF1 AIM2 NIPBL CX3CR1 | 5.54e-05 | 498 | 159 | 12 | M1741 |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP | 6.39e-05 | 163 | 159 | 7 | M8905 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | NRIP1 RBBP6 PTPN22 HEATR5A CD200R1 ARHGEF10 SCN8A ANKRD11 MACF1 AIM2 NIPBL CX3CR1 | 6.57e-05 | 507 | 159 | 12 | MM1030 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NUSAP1 H1-10 MAP9 ZKSCAN2 SYT2 KIF20B SCN8A SERTAD4 ASPM UHRF1 MAP7D2 CKAP2 DNMT1 MYBL1 | 7.25e-05 | 680 | 159 | 14 | MM456 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NUSAP1 H1-10 L3MBTL2 KIAA0586 KIF20B SPATS2L SERTAD4 ASPM UHRF1 CKAP2 ADGRL2 DNMT1 MYBL1 | 7.57e-05 | 597 | 159 | 13 | MM1309 |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 8.63e-05 | 171 | 159 | 7 | M2947 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 9.50e-05 | 300 | 159 | 9 | M39059 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.07e-04 | 177 | 159 | 7 | M39245 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ABCC1 KATNAL2 SETX BCLAF1 TTC14 HEATR5A FAM98A MAP7 RFX4 KIF20B ZNF800 PLAA RBM27 ASPM ANKRD11 MAP7D2 NIPBL DNMT1 | 8.66e-08 | 532 | 157 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | UNC13B NUSAP1 MAGI1 KATNAL2 ZNF536 BCLAF1 KIAA0586 FAM171B RFX4 ZNF800 STOX2 ASPM MAP7D2 | 3.52e-07 | 298 | 157 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | KATNAL2 ZNF536 SETX HEATR5A FAM171B RFX4 ZNF800 TET1 ASPM ANKRD11 MAP7D2 NIPBL | 5.35e-07 | 259 | 157 | 12 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | UNC13B NUSAP1 MAGI1 KATNAL2 ZNF536 CPNE9 BCLAF1 KIAA0586 ZKSCAN2 FAM171B BCOR RFX4 KIF20B MEOX2 ZNF800 STOX2 PTPN13 CLCN3 PIK3CB ASPM MAP7D2 MACF1 NIPBL | 1.02e-06 | 986 | 157 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | UNC13B NUSAP1 MAGI1 KATNAL2 ZNF536 RBBP6 IFT74 CEP162 KIAA0586 ZKSCAN2 MAP7 RFX4 KIF20B ZNF800 STOX2 CLCN3 PIK3CB ASPM UHRF1 MAP7D2 FGD6 NIPBL MYBL1 | 1.07e-06 | 989 | 157 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | KATNAL2 ZNF536 SETX CPNE9 SYT3 HEATR5A FAM171B MAP7 RFX4 CCNT1 ZNF800 STOX2 PTPN13 PLAA CLCN3 FMN1 TET1 ASPM ANKRD11 SLX4IP MAP7D2 EIF2A NIPBL | 1.17e-06 | 994 | 157 | 23 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | NUSAP1 MAGI1 KATNAL2 ZNF536 BCLAF1 FAM171B RFX4 KIF20B ZNF800 ASPM MAP7D2 | 1.29e-06 | 232 | 157 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NUSAP1 KATNAL2 ZNF536 SETX L3MBTL2 SYT3 SWT1 IFT74 BCLAF1 VPS50 RBM26 TTC14 KIF20B ZNF800 ZNF878 CEP120 ZNF644 TET1 SERTAD4 ASPM ANKRD12 AIM2 FGD6 NIPBL MYBL1 | 5.35e-06 | 1252 | 157 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NUSAP1 KATNAL2 SETX L3MBTL2 SWT1 RBBP6 IFT74 BCLAF1 VPS50 KIAA0586 RBM26 TTC14 FAM171B KIF20B ZNF800 CEP120 RBM27 ZNF644 TET1 SCN8A ASPM MACF1 NIPBL DNMT1 MYBL1 | 5.73e-06 | 1257 | 157 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | SFRP2 SETX SWT1 VPS50 KIAA0586 HEATR5A TRAPPC8 XRCC5 KIF20B ACSL3 PLAA RBM27 PIK3CB FMN1 TET1 MAP7D2 ANKRD12 CKAP2 MYBL1 | 8.94e-06 | 810 | 157 | 19 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 9.27e-06 | 139 | 157 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | NUSAP1 SETX CPNE9 BCLAF1 HEATR5A FAM98A TRAPPC8 KIF20B CCNT1 FMN1 TET1 ASPM ANKRD11 NIPBL | 1.07e-05 | 469 | 157 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_1000_k-means-cluster#3 | KATNAL2 SFRP2 CPNE9 CHRNA9 SYT3 ROR1 SYT6 SYT2 MAP7 ZNF878 TET1 C2orf80 AIM2 UNC13A SHISA6 HERC5 GABRA5 | 1.10e-05 | 675 | 157 | 17 | Arv_SC-LF_1000_K3 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | H1-10 SFRP2 RBBP6 CFTR FAM98A MAP7 XRCC5 KIF20B MEOX2 ADORA1 PTPN13 MEX3A FMN1 ASPM UHRF1 SCPEP1 HAS2 FGD6 | 1.13e-05 | 749 | 157 | 18 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NUSAP1 MAGI1 KATNAL2 ZNF536 TCF20 SWT1 RBBP6 IFT74 CEP162 KIAA0586 RFX4 KIF20B ZNF800 NFKB1 ASPM MAP7D2 SCPEP1 NIPBL MYBL1 | 1.28e-05 | 831 | 157 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | NUSAP1 MAGI1 RBBP6 IFT74 CEP162 KIAA0586 KIF20B ASPM FGD6 NIPBL MYBL1 | 2.09e-05 | 311 | 157 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | USP53 NRIP1 NBEAL1 BCLAF1 RBM26 TTC14 FAM171B PLAA NALCN TET1 ASPM ANKRD11 SCPEP1 ANKRD12 HAS2 BICC1 CX3CR1 MYBL1 | 2.30e-05 | 790 | 157 | 18 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NUSAP1 KATNAL2 ZNF536 SETX L3MBTL2 SWT1 RBBP6 IFT74 BCLAF1 VPS50 KIAA0586 RBM26 TTC14 FAM171B KIF20B ZNF800 CEP120 RBM27 ZNF644 TET1 SCN8A ASPM MACF1 NIPBL DNMT1 MYBL1 | 2.51e-05 | 1459 | 157 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NUSAP1 MAGI1 KATNAL2 FAT4 ZNF536 SFRP2 RBBP6 BCLAF1 FAM171B RFX4 KIF20B ZNF800 RBM27 ASPM MAP7D2 ANKRD12 | 2.89e-05 | 654 | 157 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | LRRC39 CACNA1C FAT4 SETX SYT3 TTC14 KIF20B SRSF12 FMN1 ZNF644 MACF1 ANKRD12 AIM2 FGD6 EIF2AK2 NIPBL BICC1 | 3.80e-05 | 744 | 157 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_2500_k-means-cluster#5 | CCDC169 KATNAL2 SFRP2 CPNE9 CHRNA9 SYT3 ROR1 SYT6 ZKSCAN2 SYT2 MAP7 RGS7 SH3PXD2B ZNF878 F11R TET1 C2orf80 AIM2 UNC13A SHISA6 HERC5 GABRA5 | 4.11e-05 | 1152 | 157 | 22 | Arv_SC-LF_2500_K5 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | H1-10 SFRP2 CFTR MAP7 ADORA1 PTPN13 MEX3A FMN1 UHRF1 SCPEP1 PCDH7 BICC1 | 4.22e-05 | 398 | 157 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | NUSAP1 HEATR5A KIF20B CD200R1 MEX3A F11R TET1 ASPM UHRF1 CKAP2 ADGRL2 PCDH7 | 5.61e-05 | 410 | 157 | 12 | GSM791122_500 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#2 | SFRP2 CPNE9 SYT3 ROR1 SYT6 SYT2 MAP7 RGS7 ZNF878 AIM2 UNC13A SHISA6 HERC5 GABRA5 | 6.60e-05 | 554 | 157 | 14 | Arv_SC_fibroblast_1000_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#1 | SFRP2 CPNE9 SYT3 ROR1 SYT6 SYT2 MAP7 RGS7 ZNF878 AIM2 UNC13A SHISA6 HERC5 GABRA5 | 6.99e-05 | 557 | 157 | 14 | Arv_SC-HD_1000_K1 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | NUSAP1 H1-10 HEATR5A KIF20B MEX3A F11R TET1 ASPM UHRF1 CKAP2 ADGRL2 PCDH7 | 7.56e-05 | 423 | 157 | 12 | GSM791126_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.77e-05 | 298 | 157 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | NUSAP1 KATNAL2 ZNF536 MAP7 RFX4 KIF20B ZNF800 STOX2 PIK3CB ASPM MAP7D2 FGD6 NIPBL | 8.77e-05 | 498 | 157 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 9.36e-05 | 192 | 157 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NRIP1 NBEAL1 BCLAF1 RBM26 TTC14 PLAA ZC2HC1A NALCN TET1 ASPM ANKRD11 SCPEP1 ANKRD12 HAS2 BICC1 CX3CR1 MYBL1 | 9.41e-05 | 801 | 157 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MAGI1 KATNAL2 ZNF536 RBBP6 FAM171B RFX4 ZNF800 RBM27 ASPM MAP7D2 | 1.70e-04 | 328 | 157 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#3 | 1.72e-04 | 267 | 157 | 9 | Arv_SC-HD_500_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#1 | 1.72e-04 | 267 | 157 | 9 | Arv_SC_fibroblast_500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.14e-04 | 275 | 157 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MAGI1 TCF20 SWT1 RBBP6 IFT74 CEP162 KIAA0586 KIF20B ZC2HC1A ZNF644 NFKB1 TET1 MARF1 MACF1 SCPEP1 NIPBL | 2.24e-04 | 780 | 157 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | H1-10 SFRP2 CFTR FAM98A MAP7 ADORA1 PTPN13 MEX3A FMN1 TET1 ASPM UHRF1 SCPEP1 HAS2 PCDH7 BICC1 | 2.34e-04 | 783 | 157 | 16 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_500_k-means-cluster#3 | SFRP2 CPNE9 CHRNA9 SYT3 SYT6 MAP7 UNC13A SHISA6 HERC5 GABRA5 | 2.38e-04 | 342 | 157 | 10 | Arv_SC-LF_500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 2.47e-04 | 118 | 157 | 6 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.50e-04 | 17 | 157 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | USP53 NRIP1 NBEAL1 BCLAF1 TTC14 FAM171B ZNF800 PLAA NALCN TET1 ASPM ANKRD11 SCPEP1 HAS2 BICC1 MYBL1 | 2.85e-04 | 797 | 157 | 16 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | UNC13B NUSAP1 KATNAL2 ZNF536 SETX SWT1 IFT74 BCLAF1 CEP162 KIAA0586 TMEM154 FAM171B KIF20B ADORA1 ZNF800 STOX2 FER1L4 ZNF644 SCN8A ASPM MACF1 NIPBL MYBL1 | 2.97e-04 | 1414 | 157 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.98e-04 | 18 | 157 | 3 | gudmap_kidney_P2_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | NUSAP1 MAGI1 KATNAL2 ZNF536 BCLAF1 FAM171B MAP7 RFX4 KIF20B ZNF800 ASPM MAP7D2 | 3.12e-04 | 493 | 157 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | SFRP2 CPNE9 SYT3 ROR1 SYT6 SYT2 MAP7 ZNF878 UNC13A SHISA6 HERC5 GABRA5 | 3.18e-04 | 494 | 157 | 12 | PCBC_SC_blastocyst_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | UNC13B NUSAP1 KATNAL2 SETX SWT1 IFT74 BCLAF1 CEP162 KIAA0586 FAM171B KIF20B ZNF800 STOX2 ZNF644 SCN8A ASPM MACF1 NIPBL MYBL1 | 3.20e-04 | 1060 | 157 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | UNC13B MAGI1 KATNAL2 ZNF536 CPNE9 ZKSCAN2 BCOR RFX4 ZNF800 PIK3CB ASPM MAP7D2 | 3.30e-04 | 496 | 157 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_2500_k-means-cluster#5 | CCDC169 SFRP2 CPNE9 CHRNA9 ROR1 SYT6 ZKSCAN2 SYT2 MAP7 ESYT3 SH3PXD2B ZNF878 TET1 C2orf80 UNC13A SHISA6 HERC5 GABRA5 | 3.39e-04 | 978 | 157 | 18 | ratio_SC_vs_EB_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | NUSAP1 MAGI1 KATNAL2 ZNF536 RBBP6 BCLAF1 ZKSCAN2 FAM171B MAP7 RFX4 KIF20B SRSF12 ZNF800 STOX2 RBM27 ASPM ANKRD11 MAP7D2 | 3.60e-04 | 983 | 157 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | STARD13 NUSAP1 CACNA1C FAT4 RBBP6 ROR1 BCOR KIF20B ACSL3 TET1 SERTAD4 HAS2 ADGRL2 FGD6 NIPBL MYBL1 | 3.85e-04 | 819 | 157 | 16 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#5 | SFRP2 CPNE9 CHRNA9 SYT3 ROR1 SYT6 SYT2 MAP7 UNC13A SHISA6 HERC5 GABRA5 | 3.87e-04 | 505 | 157 | 12 | Arv_SC-H9hpx_1000_K5 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | SETX SWT1 VPS50 KIAA0586 HEATR5A TRAPPC8 XRCC5 KIF20B ACSL3 RBM27 PIK3CB TET1 MAP7D2 CKAP2 FGD6 MYBL1 | 4.01e-04 | 822 | 157 | 16 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#3 | SFRP2 CPNE9 CHRNA9 SYT3 ROR1 SYT6 SYT2 MAP7 UNC13A SHISA6 HERC5 GABRA5 | 4.23e-04 | 510 | 157 | 12 | Arv_SC-hpx_blastocyst_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | LRRC39 CACNA1C FAT4 CPNE9 SYT3 BCLAF1 TTC14 KIF20B SRSF12 FMN1 MACF1 ANKRD12 AIM2 FGD6 EIF2AK2 BICC1 | 4.69e-04 | 834 | 157 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.77e-04 | 186 | 157 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | UNC13B NUSAP1 MAGI1 KATNAL2 ZNF536 IFT74 BCLAF1 CEP162 KIAA0586 RBM26 LCA5L FAM171B BCOR KIF20B ZNF800 STOX2 PIK3CB SCN8A ASPM UHRF1 NIPBL MYBL1 | 4.84e-04 | 1370 | 157 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.44e-04 | 249 | 157 | 8 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 5.51e-04 | 22 | 157 | 3 | gudmap_kidney_P0_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.90e-04 | 316 | 157 | 9 | gudmap_kidney_P3_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 7.69e-04 | 328 | 157 | 9 | GSM605756_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.78e-04 | 202 | 157 | 7 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | USP53 NRIP1 BCLAF1 KIAA0586 RBM26 ADORA1 ZNF800 CCDC62 ASPM ANKRD11 MAP7D2 SCPEP1 ANKRD12 SHISA6 MYBL1 | 8.39e-04 | 795 | 157 | 15 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | SETX SWT1 VPS50 HEATR5A TRAPPC8 XRCC5 KIF20B ACSL3 PLAA RBM27 PIK3CB TET1 MAP7D2 CKAP2 MYBL1 | 8.39e-04 | 795 | 157 | 15 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | USP53 NRIP1 NBEAL1 BCLAF1 RBM26 TTC14 NALCN TET1 ASPM ANKRD11 SCPEP1 ANKRD12 HAS2 BICC1 MYBL1 | 8.82e-04 | 799 | 157 | 15 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.06e-04 | 406 | 157 | 10 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | USP53 NRIP1 NBEAL1 BCLAF1 KIAA0586 RBM26 TTC14 ZNF800 PLAA TET1 ASPM ANKRD11 SCPEP1 ANKRD12 MYBL1 | 9.39e-04 | 804 | 157 | 15 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_1000 | KATNAL2 SFRP2 CPNE9 CHRNA9 SYT3 ROR1 SYT6 SYT2 MAP7 ZNF878 TET1 C2orf80 AIM2 UNC13A SHISA6 HERC5 GABRA5 | 9.62e-04 | 980 | 157 | 17 | Arv_SC-LF_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | UNC13B NUSAP1 MAGI1 KATNAL2 ZNF536 BCLAF1 KIAA0586 ZKSCAN2 FAM171B BCOR RFX4 ZNF800 STOX2 PIK3CB ASPM MAP7D2 | 9.73e-04 | 893 | 157 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | NUSAP1 TMEM154 PTPN22 KIF20B PTPN13 ASPM UHRF1 CKAP2 CX3CR1 DNMT1 | 9.76e-04 | 410 | 157 | 10 | GSM538387_500 |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | MAGI1 ACSL3 STOX2 SLC9A2 PTPN13 F11R SYNJ2 HAS2 ADGRL2 PCDH7 | 9.94e-04 | 411 | 157 | 10 | GSM854302_500 |
| CoexpressionAtlas | Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2 | NUSAP1 HEATR5A KIF20B ACSL3 F11R TET1 ASPM UHRF1 ADGRL2 PCDH7 | 9.94e-04 | 411 | 157 | 10 | GSM791112_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.03e-03 | 413 | 157 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | NUSAP1 CACNA1C ZNF536 CHRNA9 BCLAF1 TTC14 KIF20B FMN1 MAP7D2 MACF1 FGD6 | 1.11e-03 | 492 | 157 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | UNC13B SETX SWT1 VPS50 TRAPPC8 ACSL3 PLAA RBM27 CCDC62 TET1 MAP7D2 ANKRD12 CKAP2 FGD6 MYBL1 | 1.14e-03 | 820 | 157 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | SFRP2 CPNE9 ROR1 SYT6 SYT2 MAP7 ZNF878 UNC13A SHISA6 HERC5 GABRA5 | 1.17e-03 | 495 | 157 | 11 | PCBC_SC_fibroblast_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | NUSAP1 NRIP1 KDM5B RASA2 KIF20B MEX3A TET1 ASPM UHRF1 CX3CR1 | 1.23e-03 | 423 | 157 | 10 | GSM476655_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.27e-03 | 284 | 157 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.32e-03 | 162 | 157 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#2 | KATNAL2 SFRP2 CPNE9 SYT3 ROR1 SYT6 SYT2 MAP7 RGS7 ESYT3 ZNF878 F11R TET1 AIM2 UNC13A SHISA6 HERC5 GABRA5 | 1.43e-03 | 1108 | 157 | 18 | Arv_SC_fibroblast_2500_K2 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.45e-03 | 165 | 157 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | NRIP1 MAP9 RBBP6 BCLAF1 CEP162 KIF20B ZNF800 PTPN13 ZNF644 ANKRD11 ANKRD12 NIPBL | 8.85e-12 | 198 | 161 | 12 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | NRIP1 MAP9 SETX RBBP6 BCLAF1 CEP162 LCA5L ZNF644 ANKRD11 ANKRD12 PCDH7 NIPBL | 9.39e-12 | 199 | 161 | 12 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | NRIP1 SETX BCLAF1 SPATS2L RBM27 SYNJ2 ANKRD11 ANKRD12 PCDH7 NIPBL | 3.10e-09 | 199 | 161 | 10 | 19674e1eaeb51e4196d847cb62aa437c852951d3 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SETX BCLAF1 ZNF644 ANKRD11 MACF1 ANKRD12 SRRM2 EIF2AK2 NIPBL HERC5 | 3.26e-09 | 200 | 161 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | H1-10 RBBP6 BCLAF1 ANKRD11 MACF1 ANKRD12 SRRM2 EIF2AK2 NIPBL HERC5 | 3.26e-09 | 200 | 161 | 10 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | RBBP6 BCLAF1 SPATS2L ZNF644 ANKRD11 ANKRD12 EIF2AK2 PCDH7 NIPBL | 4.83e-08 | 199 | 161 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-07 | 175 | 161 | 8 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.00e-07 | 179 | 161 | 8 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.85e-07 | 185 | 161 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.18e-07 | 187 | 161 | 8 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.18e-07 | 187 | 161 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.72e-07 | 190 | 161 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-07 | 191 | 161 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.91e-07 | 191 | 161 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.11e-07 | 192 | 161 | 8 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.53e-07 | 194 | 161 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 5.97e-07 | 196 | 161 | 8 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.97e-07 | 196 | 161 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 197 | 161 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.20e-07 | 197 | 161 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.45e-07 | 198 | 161 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.45e-07 | 198 | 161 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-07 | 198 | 161 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.70e-07 | 199 | 161 | 8 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.70e-07 | 199 | 161 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 6.70e-07 | 199 | 161 | 8 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.70e-07 | 199 | 161 | 8 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 6.70e-07 | 199 | 161 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.70e-07 | 199 | 161 | 8 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.70e-07 | 199 | 161 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 6.95e-07 | 200 | 161 | 8 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 6.95e-07 | 200 | 161 | 8 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-07 | 200 | 161 | 8 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 7.21e-07 | 138 | 161 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.79e-06 | 169 | 161 | 7 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 171 | 161 | 7 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-06 | 172 | 161 | 7 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-06 | 174 | 161 | 7 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-06 | 174 | 161 | 7 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-06 | 176 | 161 | 7 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 177 | 161 | 7 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 177 | 161 | 7 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-06 | 180 | 161 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-06 | 180 | 161 | 7 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 186 | 161 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 186 | 161 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.26e-06 | 186 | 161 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 187 | 161 | 7 | 4d12c70c8ed922fbc8f7b139145611203735cab4 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 5.44e-06 | 187 | 161 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 187 | 161 | 7 | e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 187 | 161 | 7 | e851ee46a6b4068a7bd7602ee183c0ace50ee4dd | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.64e-06 | 188 | 161 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 5.64e-06 | 188 | 161 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-06 | 189 | 161 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 6.04e-06 | 190 | 161 | 7 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.25e-06 | 191 | 161 | 7 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.25e-06 | 191 | 161 | 7 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.25e-06 | 191 | 161 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 6.25e-06 | 191 | 161 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.25e-06 | 191 | 161 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-06 | 191 | 161 | 7 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.47e-06 | 192 | 161 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-06 | 126 | 161 | 6 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.69e-06 | 193 | 161 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.69e-06 | 193 | 161 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 6.69e-06 | 193 | 161 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 194 | 161 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.92e-06 | 194 | 161 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.16e-06 | 195 | 161 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.40e-06 | 196 | 161 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 7.40e-06 | 196 | 161 | 7 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.40e-06 | 196 | 161 | 7 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 7.40e-06 | 196 | 161 | 7 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.65e-06 | 197 | 161 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.91e-06 | 198 | 161 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.91e-06 | 198 | 161 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | 7.91e-06 | 198 | 161 | 7 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 199 | 161 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 199 | 161 | 7 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 8.17e-06 | 199 | 161 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 199 | 161 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 8.17e-06 | 199 | 161 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.26e-06 | 131 | 161 | 6 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.45e-06 | 200 | 161 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.45e-06 | 200 | 161 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 8.45e-06 | 200 | 161 | 7 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.45e-06 | 200 | 161 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 8.45e-06 | 200 | 161 | 7 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 8.45e-06 | 200 | 161 | 7 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.45e-06 | 200 | 161 | 7 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 8.45e-06 | 200 | 161 | 7 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.45e-06 | 200 | 161 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.63e-06 | 132 | 161 | 6 | f1b448efccbf87caa86d1a794c43a230a4b0758e | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.26e-05 | 141 | 161 | 6 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 1.72e-05 | 149 | 161 | 6 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 158 | 161 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 158 | 161 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| Disease | Malignant neoplasm of breast | ABCC1 NRIP1 SFRP2 SYT3 INPP5K ROR1 CD109 TRAPPC8 SLC9A2 SYNJ2 PIK3CB ZNF644 HEATR9 MAP7D2 MACF1 GGA1 NIPBL DNMT1 | 1.36e-05 | 1074 | 154 | 18 | C0006142 |
| Disease | Adenoid Cystic Carcinoma | 1.83e-04 | 100 | 154 | 5 | C0010606 | |
| Disease | Bipolar Disorder | MAGI1 CACNA1C ROR1 TRPM2 GRIN2A RFX4 ARHGEF10 SCN8A DNMT1 GABRA5 | 2.14e-04 | 477 | 154 | 10 | C0005586 |
| Disease | intracranial volume measurement | 6.78e-04 | 33 | 154 | 3 | EFO_0004886 | |
| Disease | cortical surface area measurement | MAGI1 ZNF536 SFRP2 NBEAL1 MYO9B CEP162 ROR1 SYT2 RFX4 KIF20B CEP120 NFKB1 UHRF1 MACF1 ADGRL2 FGD6 PCDH7 | 6.84e-04 | 1345 | 154 | 17 | EFO_0010736 |
| Disease | chronotype measurement | ZNF536 RGSL1 TCF20 RBBP6 RFX4 SYT10 RGS7 CD200R1 ESYT3 TET1 SCN8A BICC1 PCYOX1 | 7.59e-04 | 882 | 154 | 13 | EFO_0008328 |
| Disease | Developmental delay (disorder) | 9.51e-04 | 37 | 154 | 3 | C0424605 | |
| Disease | lung cancer (is_marker_for) | 1.11e-03 | 39 | 154 | 3 | DOID:1324 (is_marker_for) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.43e-03 | 157 | 154 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | circadian rhythm | 1.69e-03 | 163 | 154 | 5 | EFO_0004354 | |
| Disease | epilepsy (implicated_via_orthology) | 1.69e-03 | 163 | 154 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth Disease | 1.73e-03 | 12 | 154 | 2 | C0007959 | |
| Disease | polychlorinated biphenyls measurement, gestational serum measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0007042, EFO_0007964 | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 1.91e-03 | 47 | 154 | 3 | EFO_0004530, EFO_0005202 | |
| Disease | Mood Disorders | 1.93e-03 | 168 | 154 | 5 | C0525045 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.03e-03 | 13 | 154 | 2 | C0036996 | |
| Disease | aortic measurement | 2.10e-03 | 251 | 154 | 6 | EFO_0020865 | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 2.36e-03 | 14 | 154 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | Saldino-Noonan Syndrome | 2.36e-03 | 14 | 154 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 2.36e-03 | 14 | 154 | 2 | C0024507 | |
| Disease | eating disorder, bipolar disorder | 2.36e-03 | 14 | 154 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | Schizophrenia | MAGI1 CACNA1C NRIP1 MYO9B GRIN2A ARHGEF11 ADORA1 PLAA PIK3CB TET1 DNMT1 GABRA5 | 2.38e-03 | 883 | 154 | 12 | C0036341 |
| Disease | disease recurrence, colon carcinoma | 2.42e-03 | 51 | 154 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.51e-03 | 108 | 154 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | Epilepsy | 2.60e-03 | 109 | 154 | 4 | C0014544 | |
| Disease | Alcoholic Intoxication, Chronic | 2.91e-03 | 268 | 154 | 6 | C0001973 | |
| Disease | brain aneurysm | 2.96e-03 | 113 | 154 | 4 | EFO_0003870 | |
| Disease | forced expiratory volume | HYKK ZKSCAN2 GRIN2A ARMC2 SLC9A2 SPATS2L CEP120 UHRF1 ADGRL2 FGD6 HERC5 | 2.96e-03 | 789 | 154 | 11 | EFO_0004314 |
| Disease | venous thromboembolism | 2.96e-03 | 460 | 154 | 8 | EFO_0004286 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.10e-03 | 16 | 154 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Drug-induced agranulocytosis | 3.10e-03 | 16 | 154 | 2 | HP_0012235 | |
| Disease | succinylcarnitine measurement | 3.10e-03 | 16 | 154 | 2 | EFO_0020020 | |
| Disease | Colorectal Neoplasms | 3.42e-03 | 277 | 154 | 6 | C0009404 | |
| Disease | sleep quality | 3.45e-03 | 118 | 154 | 4 | EFO_0005272 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.66e-03 | 195 | 154 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | UNC13B NUSAP1 ABCC1 SFRP2 CFTR CD109 GRIN2A SLC1A7 ADORA1 CCDC62 | 3.91e-03 | 702 | 154 | 10 | C0009402 |
| Disease | borna disease (biomarker_via_orthology) | 3.92e-03 | 18 | 154 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | Tourette syndrome, schizophrenia | 3.92e-03 | 18 | 154 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.07e-03 | 200 | 154 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | neuroimaging measurement | MAGI1 SFRP2 NBEAL1 ROR1 RBM26 ZDHHC5 FAM98A ARHGEF11 OMG KIF20B MACF1 FGD6 PCDH7 | 4.09e-03 | 1069 | 154 | 13 | EFO_0004346 |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 4.40e-03 | 63 | 154 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | unipolar depression, memory performance, cognitive function measurement | 4.83e-03 | 20 | 154 | 2 | EFO_0003761, EFO_0004874, EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSDPYVTVQVGKTKK | 696 | Q9UPW8 | |
| PSQRKAKIYTQASKS | 1196 | Q68DN1 | |
| FARNKVSKDPSSYVK | 476 | A0FGR9 | |
| SIYKSSQGSKKVRLQ | 1001 | O15013 | |
| PEATYQKEIKTTNGK | 891 | Q9BXX2 | |
| YRKETKSNSFISIPK | 371 | Q6UB99 | |
| YTKNNTIAPKKASHR | 391 | Q6UB99 | |
| TKSTKPYKNGQLSKV | 1176 | P13569 | |
| APKAAAYARKQSVKS | 141 | Q0P641 | |
| KTGRYNPAKQKTVSA | 181 | A6NNP5 | |
| SNKKNSPTSLLIYKD | 596 | Q6P9F0 | |
| KDRGPTKATTTKLVY | 611 | P26358 | |
| LNKKVSASSGDPQKY | 211 | P30542 | |
| QYKSVTKPKPLSQAE | 91 | O14862 | |
| KLDPFYQPSVSKQKT | 11 | Q8NEN0 | |
| SKYFTPVTKNVKVGT | 2986 | Q6V0I7 | |
| ILKYIGKPKSSSQST | 536 | O15085 | |
| LYQPQKKVKSEGTDS | 1336 | O95490 | |
| LTNSKKPKSVTDIYL | 56 | P49238 | |
| TKVYSKLPESNLKAA | 371 | Q9UGM1 | |
| TALQKKTQGYLESPK | 401 | P17544 | |
| SVPSAKVSLKEYRAK | 381 | O60563 | |
| SYSKTPKIERSDVSK | 36 | Q6UB98 | |
| FKSKKQKPSRVLYSS | 411 | Q6UB98 | |
| LLQKYTDNSEKPSGK | 1346 | Q6W2J9 | |
| SPKRKQNKSTEHYLS | 836 | Q9H694 | |
| ILSKSKSYKNEVTPS | 551 | Q8IZT6 | |
| VQTDKSIYKPGQTVK | 131 | P01023 | |
| TTPYLQSVKKKVQFD | 596 | Q8WWK9 | |
| STVEKSRQKYKPASL | 176 | Q6ZS30 | |
| QRKEVKKDYPSNTTS | 26 | Q86U06 | |
| KTVYNPAALKAAQKT | 696 | Q5T8P6 | |
| KKYPSPQKTRSESSE | 116 | Q9P2N5 | |
| KRSSSAKYGSKENPI | 831 | Q15283 | |
| TGKKEVSKQTVAYSP | 156 | Q33E94 | |
| TTQQKKKPLSETYEK | 1026 | Q68DA7 | |
| KQAAKVVKASSPSYL | 561 | Q9H0B3 | |
| TTVAEKPKNIKKNRY | 46 | Q9Y2R2 | |
| KKAGQERPSVTSYKE | 146 | Q9UJX3 | |
| QSGSKQSTPKRTKSY | 211 | Q96QZ7 | |
| SYKVQDKKNASSRPA | 26 | Q14244 | |
| AYTKSPKVTKRTTFQ | 11 | Q49MG5 | |
| YKSSPTRNIEKKKAT | 216 | Q96T17 | |
| ENYLEKTKSKAAPSR | 511 | Q969R5 | |
| KKNQPGKYSQLVVET | 41 | Q92522 | |
| TVSPKKAVATLKIYN | 1161 | A9Z1Z3 | |
| LSYNKIKTVPKELSN | 136 | Q96DD0 | |
| KSGKEKTQPSLYSAT | 5261 | Q5CZC0 | |
| YIEEKTKTKYTGNPT | 276 | Q9UHG3 | |
| SNNVSIPTTIYKAKK | 681 | Q9HCI6 | |
| KKSKQPLYSSIVTVE | 941 | O60245 | |
| YPKIVKKSSDTAENN | 86 | Q8IYT4 | |
| AKLVKNPYKASSTTT | 36 | A0A1B0GV90 | |
| QKVAIRPSSKKTYSL | 1696 | Q96Q89 | |
| DSKIQKYSPSESAKV | 2561 | Q6KC79 | |
| KNEYEKDSPRLTKTN | 1051 | P48552 | |
| YPKVSSTKSVQADRK | 351 | O95447 | |
| QPSCTKAYKKETNET | 81 | Q8TD46 | |
| KVVSPKYLGSRTSEK | 96 | Q9UJY5 | |
| KPSEEKTSESKKTYN | 406 | P31644 | |
| PKSRSKKATNAVDLY | 296 | Q9UGL1 | |
| EGNYKSEVNSKPRKE | 176 | P50222 | |
| NRDSKVPSEGKKSLY | 151 | Q9BXS6 | |
| VPFKIISSSKNSYKL | 386 | Q9Y5G0 | |
| TYKAFVESQQKSPGK | 1356 | Q9UPN3 | |
| TRKQPDVDRVTKTYK | 6931 | Q9UPN3 | |
| NVSTKPSNIVKYPEK | 1351 | Q7Z6E9 | |
| KATYDTKRPNEETKS | 1546 | Q7Z6E9 | |
| KSAKRTPESTQIGQY | 86 | Q9Y6X9 | |
| KKENSYVNLKRTIPT | 376 | Q9UII4 | |
| KSPSKTYIQLKTRDE | 461 | Q6YHK3 | |
| KSQESDYQPIKKNVT | 566 | Q96LB3 | |
| SKYTKSPGKNSSIQL | 2021 | Q86XA9 | |
| EYVLKISNTKASKNP | 61 | A2RU49 | |
| VSSTQRKRQQYGKPK | 76 | Q13936 | |
| FKQYRTKTTPVVKSP | 156 | O00341 | |
| YDPENSKNSSRSKTK | 346 | P19525 | |
| SLQYDKDTKPNPKAS | 406 | Q8N960 | |
| ESSGSRKQEKTPKDY | 716 | Q9NYF8 | |
| RNSNDYDTSEKKRKP | 251 | Q9BT40 | |
| DVYNVDSKTNISKPK | 86 | Q8IYJ1 | |
| IYKESKRPFSESKQT | 496 | Q92819 | |
| GTNVSYLKTKKTSQP | 61 | Q5TB80 | |
| TKAQFYASEKTSPKR | 136 | Q9BSJ5 | |
| NSGVAEPVYKTSQKK | 691 | Q9Y4F3 | |
| EPVYKTSQKKENLSA | 696 | Q9Y4F3 | |
| VKNYKLISKPVASDS | 346 | Q9BY44 | |
| KNSSYSPQKKEPSKA | 431 | Q6P995 | |
| INSTNKTYTLTKKKP | 681 | P10243 | |
| KTYTLTKKKPNPNTS | 686 | P10243 | |
| RTKYEEAKAPKATAN | 371 | O15547 | |
| QSKTKKPGISDVTDY | 1301 | Q12923 | |
| YPKGNAKSESRKIST | 251 | P56715 | |
| KGTSSKKVIYSQPSA | 271 | Q9Y624 | |
| AKTRKQPVKVVYSSK | 266 | P33527 | |
| DTQKYKPFKSQVKSG | 346 | Q9GZR2 | |
| LTYISKVSIATPKQK | 61 | Q9HB19 | |
| TTVKKKTLNPYFNES | 326 | Q8N9I0 | |
| KTSIKKNTLNPTYNE | 486 | Q9BQG1 | |
| KTTIKKNTLNPVYNE | 416 | Q5T7P8 | |
| SKSYDKTTQNVKEPG | 401 | P49802 | |
| PSKIVSTYLQESQKK | 776 | A5PLK6 | |
| TKSKTIYKLNGVSER | 216 | Q96HF1 | |
| KESSPRVIQKKYATG | 826 | Q9Y3M8 | |
| TATKQPSSPYEDKDK | 326 | Q9UQ35 | |
| NKVKNKKTVSIPSYI | 111 | Q6UWF3 | |
| KEKIYAVRSVVPNKS | 11 | Q9NUQ6 | |
| RTGISKPYNVKQIKT | 1156 | O15056 | |
| PKSLETSAFVKSYKN | 406 | Q9HB40 | |
| SQTEKLAKVYQPKRS | 241 | Q8NCA5 | |
| KALRAKTNTYIKTPV | 256 | Q5U5Q3 | |
| SRPDKKSKKQQDSTY | 436 | P46977 | |
| KQKSVKEISSYTPKD | 711 | Q7Z333 | |
| ESAVKTNPSKYSSLK | 301 | Q6ZSJ9 | |
| STKTINPSKYQTIRK | 416 | P42338 | |
| SNPITTSKITYFKRK | 66 | Q9NUC0 | |
| KQQLKAETTPLKESY | 551 | Q5T5J6 | |
| TKIPKQYRTKETTFG | 301 | P23515 | |
| KSPKGYTNSETKVQT | 226 | Q8WXF0 | |
| STIQNSPTKKRKKYE | 391 | Q5VYV7 | |
| KKPTVVSYQENDRQK | 1161 | Q8NFU7 | |
| KAKPVNSKPDSAYRS | 56 | O95573 | |
| PKYSTNEAKKREVLS | 301 | P51790 | |
| PKKYAITSVPQSEKS | 926 | Q70EK8 | |
| SQKPYKIDSKQASLL | 906 | Q01973 | |
| SRKKSDYSLNKVNAP | 591 | Q96JG6 | |
| QRPEAKTSGSEKKYL | 21 | Q5M7Z0 | |
| KAVYKQTHSKARNSP | 76 | Q8N8B7 | |
| IPKKNVPTSKRETYT | 56 | P82933 | |
| KSTKNYKNIEEPQGV | 531 | O43511 | |
| NQPKSSIVSLYKKLE | 546 | Q9UBY0 | |
| APEQSLKKTKTSEYP | 36 | Q5MJ09 | |
| KALRAKTNTYIKTPV | 156 | A1L020 | |
| SKDTEFGYQPKTIKN | 196 | Q9BQR3 | |
| PTEKSKSTVNFSYKT | 236 | Q9P2F5 | |
| FIDKYKKTSNASRPN | 421 | A1X283 | |
| SQKVKKYVRVSQDTP | 136 | O94759 | |
| APKQSLQKTKTIEYL | 36 | Q5MJ10 | |
| EEKRSKPIKAYSTEN | 681 | Q6ZV73 | |
| NKVLSVYEAPKTNVK | 476 | A2RTY3 | |
| QIKKYSSVSEPAKVS | 771 | Q9Y263 | |
| KTDSLKYIQSNRKNP | 196 | Q9HBJ7 | |
| SYDSVTKPEKEKQQR | 1946 | Q9UQD0 | |
| TQAGSSKTEKPYKSE | 606 | Q96N46 | |
| KVTLSYSKNLKPSSE | 516 | Q9Y4E1 | |
| YSKNLKPSSETKTQK | 521 | Q9Y4E1 | |
| SDPYVTVQVSKTKKR | 621 | O14795 | |
| YATQPLDKTDAKNKS | 1616 | Q9UGU0 | |
| KRKTTTKKNTLNPVY | 416 | Q6XYQ8 | |
| GKSSQRKSEKSQYEP | 961 | O15090 | |
| TDTKGKPTSRTQVYK | 156 | Q96GY0 | |
| DSQKYALSKVKPEST | 336 | Q9H582 | |
| KNKYSIEESSVGRKP | 316 | Q8N9V7 | |
| LKTTYSKSNGQPKSL | 666 | Q9C0B5 | |
| SKKTKVEPYSLTAQQ | 666 | Q96T88 | |
| SQSKKYSTKIENLGP | 31 | P51815 | |
| KDKNSPIVKYSVQVS | 81 | A0A0B4J280 | |
| ELTKSQVQDKPYKCT | 246 | P17098 | |
| KRVVSQSTDPSKYRK | 691 | Q63HK3 | |
| NNTKEEKTSVKYGPD | 886 | Q9Y2L5 | |
| KKYIETRKNPNQSSK | 261 | Q2TB10 | |
| YKRKRTKQEPSSQGS | 101 | Q6P9G4 | |
| KSQKYAEQVSEPKSD | 316 | Q6ZSB9 | |
| SSLKNSKKYAPTEAQ | 436 | P13010 | |
| KSIRTQTDFYATKPK | 676 | Q9BVV6 | |
| TLKKKTPGVQSYESS | 91 | C9JN71 | |
| SKTDPVTGAVKNTKY | 861 | Q8IZF0 | |
| RGYTKNDFEPVKQSK | 1601 | Q13459 | |
| KTKDNFKRSVASKYP | 1081 | Q12879 | |
| GASSEKNKKSYPQVK | 71 | P19838 |